跳至主要内容
临床试验/ACTRN12610000024044
ACTRN12610000024044招募中4 期

The use of continuous subcutaneous insulin infusion with real-time continuous glucose monitoring system and low glucose suspend feature (CSII + RT-CGMS + LGS) versus continuous subcutaneous insulin infusion only (CSII) in patients with type 1 diabetes (T1D) with impaired awareness of hypoglycaemia - a randomised controlled trial

Princess Margaret Hospital for Children0 个研究点目标入组 100 人开始时间: 2010年1月8日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
4 Years 至 50 Years(—)
性别
All

入选标准

  • Duration of diabetes greater than or equal 12 months
  • On insulin pump therapy greater than or equal to 6 months
  • Glycated haemaglobin (HbA1C) between 6 and 8.5%
  • Impaired awareness of hypoglycaemia

排除标准

  • Has adrenal insufficiency
  • Has growth hormone insufficiency
  • Has multiple pituitary hormone deficiency
  • Is pregnant

研究者

发起方
Princess Margaret Hospital for Children

相似试验